Bangalore, India, 560085
This combination tablet is formulated to manage Type 2 Diabetes Mellitus effectively. It combines three potent antidiabetic agents: Sitagliptin (50mg) – a DPP-4 inhibitor that enhances the body’s natural incretin hormones, improving insulin secretion and reducing glucagon levels, thereby controlling blood sugar. Glimepiride (2mg) – a sulfonylurea that stimulates pancreatic beta cells to release insulin, reducing fasting and postprandial blood glucose levels. Metformin (1000mg) – a biguanide that improves insulin sensitivity, decreases hepatic glucose production, and promotes glucose uptake in muscles. This triple combination provides comprehensive glycemic control for patients inadequately managed with diet, exercise, and single or dual antidiabetic therapy.